234 related articles for article (PubMed ID: 29309879)
1. Anti-nociceptive Role of CXCL1 in a Murine Model of Peripheral Nerve Injury-induced Neuropathic Pain.
Cao L; Malon JT
Neuroscience; 2018 Feb; 372():225-236. PubMed ID: 29309879
[TBL] [Abstract][Full Text] [Related]
2. Differential lumbar spinal cord responses among wild type, CD4 knockout, and CD40 knockout mice in spinal nerve L5 transection-induced neuropathic pain.
Cao L; Beaulac H; Eurich A
Mol Pain; 2012 Dec; 8():88. PubMed ID: 23249743
[TBL] [Abstract][Full Text] [Related]
3. Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain.
Malon JT; Maddula S; Bell H; Cao L
Neuron Glia Biol; 2011 May; 7(2-4):117-28. PubMed ID: 22377050
[TBL] [Abstract][Full Text] [Related]
4. Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain.
Cao L; Palmer CD; Malon JT; De Leo JA
Eur J Immunol; 2009 Dec; 39(12):3562-9. PubMed ID: 19750482
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CD137L to Sensory Hypersensitivity in a Murine Model of Neuropathic Pain.
Wakley AA; Leeming R; Malon J; Arabatzis TJ; Yuen Koh W; Cao L
eNeuro; 2018; 5(5):. PubMed ID: 30417077
[TBL] [Abstract][Full Text] [Related]
6. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain.
Cao L; DeLeo JA
Eur J Immunol; 2008 Feb; 38(2):448-58. PubMed ID: 18196515
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic Identification of Spinal Cord-Infiltrating CD4
Draleau K; Maddula S; Slaiby A; Nutile-McMenemy N; De Leo J; Cao L
J Pain Relief; 2014 Jun; Suppl 3():003. PubMed ID: 25143871
[TBL] [Abstract][Full Text] [Related]
8. Participation of CXCL1 in the glial cells during neuropathic pain.
Moraes TR; Elisei LS; Malta IH; Galdino G
Eur J Pharmacol; 2020 May; 875():173039. PubMed ID: 32119843
[TBL] [Abstract][Full Text] [Related]
9. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.
Chen G; Park CK; Xie RG; Berta T; Nedergaard M; Ji RR
Brain; 2014 Aug; 137(Pt 8):2193-209. PubMed ID: 24919967
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide contributes to peripheral nerve injury-induced mechanical hypersensitivity through CCL5 and p38 pathways.
Malon JT; Cao L
J Neuroimmunol; 2016 Aug; 297():68-75. PubMed ID: 27397078
[TBL] [Abstract][Full Text] [Related]
11. The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain.
Cao L; Tanga FY; Deleo JA
Neuroscience; 2009 Jan; 158(2):896-903. PubMed ID: 18976692
[TBL] [Abstract][Full Text] [Related]
12. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons.
Zhang ZJ; Cao DL; Zhang X; Ji RR; Gao YJ
Pain; 2013 Oct; 154(10):2185-2197. PubMed ID: 23831863
[TBL] [Abstract][Full Text] [Related]
13. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of CXCL1 and CXCR2 contributes to remifentanil-induced hypernociception via modulating spinal NMDA receptor expression and phosphorylation in rats.
Yang LH; Xu GM; Wang Y
Neurosci Lett; 2016 Jul; 626():135-41. PubMed ID: 26724371
[TBL] [Abstract][Full Text] [Related]
15. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
Manjavachi MN; Costa R; Quintão NL; Calixto JB
Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
[TBL] [Abstract][Full Text] [Related]
16. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
[TBL] [Abstract][Full Text] [Related]
17. Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice.
Manjavachi MN; Passos GF; Trevisan G; Araújo SB; Pontes JP; Fernandes ES; Costa R; Calixto JB
Neuropharmacology; 2019 Jun; 151():136-143. PubMed ID: 30991054
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.
Cao DL; Zhang ZJ; Xie RG; Jiang BC; Ji RR; Gao YJ
Exp Neurol; 2014 Nov; 261():328-36. PubMed ID: 24852102
[TBL] [Abstract][Full Text] [Related]
19. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
[TBL] [Abstract][Full Text] [Related]
20. Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain.
Tanga FY; Raghavendra V; Nutile-McMenemy N; Marks A; Deleo JA
Neuroscience; 2006 Jul; 140(3):1003-10. PubMed ID: 16600520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
